A PROSPECTIVE INTRA-INDIVIDUAL BLINDED COMPARISON OF 18F-PSMA-1007 AND 68GA-PSMA-11 PET/CT IMAGING IN PATIENTS WITH CONFIRMED PROSTATE CANCER

被引：0
|
作者：
Debowski, M. [1 ,2 ]
Gulhane, B. [1 ,2 ]
Ramsay, S. C. [1 ,2 ]
Thomas, P. A. [1 ,2 ,3 ]
Garcia, P. [1 ,2 ]
Latter, M. [1 ,2 ]
Tapper, S. [1 ,2 ]
Pattison, D. A. [1 ,2 ]
机构：
[1] Royal Brisbane & Womens Hosp, Dept Nucl Med, Brisbane, Qld, Australia
[2] Royal Brisbane & Womens Hosp, Specialised PET Serv, Brisbane, Qld, Australia
[3] Univ Queensland, Sch Med, Brisbane, Qld, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P16
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [31] Advantage of 18F-PSMA-1007 over 68Ga-PSMA-11 PET imaging for differentiation of local recurrence vs. urinary tracer excretion
    Kambiz Rahbar
    Matthias Weckesser
    Hojjat Ahmadzadehfar
    Michael Schäfers
    Lars Stegger
    Martin Bögemann
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 1076 - 1077
  • [32] Matched-Pair Comparison of 68Ga-PSMA-11 PET/CT and 18F-PSMA-1007 PET/CT: Frequency of Pitfalls and Detection Efficacy in Biochemical Recurrence After Radical Prostatectomy
    Rauscher, Isabel
    Kroenke, Markus
    Koenig, Michael
    Gafita, Andrei
    Maurer, Tobias
    Horn, Thomas
    Schiller, Kilian
    Weber, Wolfgang
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (01) : 51 - 57
  • [33] Comparison of [18F]PSMA-1007 with [68Ga]Ga-PSMA-11 PET/CT in Restaging of Prostate Cancer Patients with PSA Relapse
    Hoffmann, Manuela A.
    von Eyben, Finn Edler
    Fischer, Nicolas
    Rosar, Florian
    Muller-Hubenthal, Jonas
    Buchholz, Hans-Georg
    Wieler, Helmut J.
    Schreckenberger, Mathias
    CANCERS, 2022, 14 (06)
  • [34] Intra-individual comparison of 68Ga-PSMA-11 and 18F-DCFPyL normal-organ biodistribution
    Ferreira, Goncalo
    Iravani, Amir
    Hofman, Michael S.
    Hicks, Rodney J.
    CANCER IMAGING, 2019, 19 (1):
  • [35] Utility of PSMA-PET derived volumetric parameters in initial risk stratification and prediction of prostate cancer metastasis - a head-to-head comparison of the radiotracers 18F-PSMA-1007 and 68Ga-PSMA-11
    Chandekar, Kunal Ramesh
    Satapathy, Swayamjeet
    Singh, Harmandeep
    Kumar, Rajender
    Kumar, Santosh
    Kakkar, Nandita
    Mittal, Bhagwant Rai
    Singh, Shrawan Kumar
    NUCLEAR MEDICINE COMMUNICATIONS, 2024, 45 (10) : 883 - 891
  • [36] Equivocal Radiotracer Uptake on 18F-PSMA-1007 PET/CT in Patients with Prostate Cancer
    Spurr, M.
    Kimura, M.
    Kulshresthra, R.
    Kabala, J.
    Challapalli, A.
    Sakthithasan, M.
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 41 - 42
  • [37] Intra-individual comparison of 68Ga-PSMA-11 and 18F-DCFPyL normal-organ biodistribution
    Gonçalo Ferreira
    Amir Iravani
    Michael S. Hofman
    Rodney J. Hicks
    Cancer Imaging, 19
  • [38] Primary Staging of Prostate Cancer Patients with [18F]PSMA-1007 PET/CT Compared with [68Ga]Ga-PSMA-11 PET/CT
    Hoffmann, Manuela A.
    Mueller-Huebenthal, Jonas
    Rosar, Florian
    Fischer, Nicolas
    von Eyben, Finn Edler
    Buchholz, Hans-Georg
    Wieler, Helmut J.
    Schreckenberger, Mathias
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (17)
  • [39] Intra-Individual Comparison between 18F-PSMA1007-PET/CT and mpMRI for Radiotherapy Planning in Patients with primary Prostate Cancer
    Marinescu, M.
    Spohn, S.
    Ceci, L.
    Kramer, M.
    Kiefer, S.
    Sigle, A.
    Fassbender, T.
    Bronsert, P.
    Nicolay, N. H.
    Bock, M.
    Ruf, J.
    Benndorf, M.
    Grosu, A. -L.
    Zamboglou, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S15 - S15
  • [40] Intra-individual comparison of 68Ga-PSMA-11-PET/CT and multi-parametric MR for imaging of primary prostate cancer
    F. L. Giesel
    F. Sterzing
    H. P. Schlemmer
    T. Holland-Letz
    W. Mier
    M. Rius
    A. Afshar-Oromieh
    K. Kopka
    J. Debus
    U. Haberkorn
    C. Kratochwil
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1400 - 1406
12345